These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8469373)

  • 1. Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells.
    Shigeri Y; Fujimoto M
    Neurosci Lett; 1993 Jan; 149(1):19-22. PubMed ID: 8469373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y stimulates luteinizing hormone-releasing hormone release from superfused hypothalamic GT1-7 cells.
    Besecke LM; Wolfe AM; Pierce ME; Takahashi JS; Levine JE
    Endocrinology; 1994 Oct; 135(4):1621-7. PubMed ID: 7925125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y receptor in cultured vascular smooth muscle cells: ligand binding and increase in cytosolic free Ca2+.
    Mihara S; Shigeri Y; Fujimoto M
    Biochem Int; 1990 Oct; 22(2):205-12. PubMed ID: 2090091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y-induced intracellular Ca2+ increases in vascular smooth muscle cells.
    Mihara S; Shigeri Y; Fujimoto M
    FEBS Lett; 1989 Dec; 259(1):79-82. PubMed ID: 2480920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP.
    Erlinge D; Brunkwall J; Edvinsson L
    Regul Pept; 1994 Mar; 50(3):259-65. PubMed ID: 8016410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of vasoconstriction and Ca2+ currents mediated by neuropeptide Y Y2 receptors.
    Lewis CJ; Evans RJ; Neild TO
    J Smooth Muscle Res; 1999; 35(5-6):147-56. PubMed ID: 10733151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
    Misra S; Mahavadi S; Grider JR; Murthy KS
    Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
    Connor M; Yeo A; Henderson G
    Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y Y1 and Y2 receptor-mediated stimulation of mitogen-activated protein kinase activity.
    Nie M; Selbie LA
    Regul Pept; 1998 Sep; 75-76():207-13. PubMed ID: 9802411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y enhances ATP-induced formation of inositol phosphates in chromaffin cells.
    Zheng J; Zhang P; Toews M; Hexum TD
    Biochem Biophys Res Commun; 1997 Oct; 239(1):287-90. PubMed ID: 9345312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y depresses GABA-mediated calcium transients in developing suprachiasmatic nucleus neurons: a novel form of calcium long-term depression.
    Obrietan K; van den Pol AN
    J Neurosci; 1996 May; 16(10):3521-33. PubMed ID: 8627385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms.
    Yu XJ; Moskowitz MA
    Br J Pharmacol; 1996 Sep; 119(2):229-32. PubMed ID: 8886402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of vascular neuropeptide Y receptors.
    Grundemar L; Jonas SE; Mörner N; Högestätt ED; Wahlestedt C; Håkanson R
    Br J Pharmacol; 1992 Jan; 105(1):45-50. PubMed ID: 1317737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors.
    Nilsson T; Edvinsson L
    Can J Physiol Pharmacol; 2000 Mar; 78(3):256-9. PubMed ID: 10721818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells.
    Jacques D; Sader S; El-Bizri N; Chouffani S; Hassan G; Shbaklo H
    Can J Physiol Pharmacol; 2000 Feb; 78(2):162-72. PubMed ID: 10737679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.
    Misra S; Murthy KS; Zhou H; Grider JR
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1154-62. PubMed ID: 15308651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y stimulation of myosin light chain phosphorylation in cultured aortic smooth muscle cells.
    Lobaugh LA; Blackshear PJ
    J Biol Chem; 1990 Oct; 265(30):18393-9. PubMed ID: 2170410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue.
    McDonald RL; Vaughan PF; Beck-Sickinger AG; Peers C
    Neuropharmacology; 1995 Nov; 34(11):1507-14. PubMed ID: 8606797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
    Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
    Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y receptor in vascular smooth muscle.
    Shigeri Y; Mihara S; Fujimoto M
    J Neurochem; 1991 Mar; 56(3):852-9. PubMed ID: 1847185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.